[Response to the editorial in Atención Primaria "Generic drug lines: all is not gold that glitters"].
作者信息
Morros Pedrós R, Velázquez García A
出版信息
Aten Primaria. 2000 Sep 30;26(5):347-8. doi: 10.1016/s0212-6567(00)78678-1.
Abstract
摘要
相似文献
1
[Response to the editorial in Atención Primaria "Generic drug lines: all is not gold that glitters"].
Aten Primaria. 2000 Sep 30;26(5):347-8. doi: 10.1016/s0212-6567(00)78678-1.
2
[Generic drug lines: all is not gold that glitters].
Aten Primaria. 1999 Oct 31;24(7):387-9.
3
Generic antiarrhythmic drugs: what constitutes equivalency.
J Interv Card Electrophysiol. 1999 Jul;3(2):145-7. doi: 10.1023/a:1009817413845.
4
Clinical Endpoint Bioequivalence Studies Are Not Sensitive: A Perspective From Generic Drugs.
Clin Pharmacol Ther. 2019 Feb;105(2):295-297. doi: 10.1002/cpt.1244. Epub 2018 Nov 19.
5
[Prescription of generic drugs].
An R Acad Nac Med (Madr). 1997;114(3):495-509.
6
[Generic drugs, a matter of bioequivalence].
Farm Hosp. 2007 Mar-Apr;31(2):73-4. doi: 10.1016/s1130-6343(07)75716-1.
7
Interchangeability of Generics-Experiences and Outlook Toward Pharmacokinetics Variability and Generic-Generic Substitution.
Clin Pharmacol Ther. 2019 Feb;105(2):292-294. doi: 10.1002/cpt.1250. Epub 2018 Nov 20.
8
Generic drugs: the benefits and risks of making the switch.
J Fam Pract. 2010 Nov;59(11):634-40.
9
Bioequivalence, therapeutic equivalence and generic drugs.
Acta Clin Belg. 2009 Sep-Oct;64(5):379-83. doi: 10.1179/acb.2009.063.
10
[Generic drugs, bioavailability, and bioequivalence].
Gac Med Mex. 1998 Jul-Aug;134(4):491-4.
本文引用的文献
1
[Generic drug lines: all is not gold that glitters].
Aten Primaria. 1999 Oct 31;24(7):387-9.
Zotero 插件